1. Rebeiz J, Kolodny E, Richardson E. Corticodentatonigral degeneration with neuronal achromasia: a progressive disorder of late adult life. Trans Am Neurol Assoc 1967;92:23-26.
  2. Rebeiz J, Kolodny E, Richardson E. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968;18:20-33.
  3. Boeve B, Lang A, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 2003;54:S15-S19.
  4. Lippa C, Smith T, Fontneau N. Corticonigral degeneration with neuronal achromasia: a clinicopathologic study of two cases. J Neurol Sci 1990;98:301-310.
  5. Lang A, Riley D, Bergeron C. Cortical-basal ganglionic degeneration. In: Calne D, ed. Neurodegenerative Diseases. Philadelphia: Saunders, 1994:877-894.
  6. Riley D, Lang A. Corticobasal ganglionic degeneration (CBGD): further observations in six additional cases. Neurology 1988;38(Supp 1):360.
  7. Gibb W, Luthert P, Marsden C. Corticobasal degeneration. Brain 1989;112:1171-1192.
  8. Kertesz A, Martinez-Lage P, Davidson W, Munoz DG. The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 2000;55(9):1368-1375.
  9. Kertesz A, Davidson W, Munoz D. Clinical and pathological overlap between frontotemporal dementia, primary progressive aphasia and corticobasal degeneration: the Pick complex. Dement Geriatr Cogn Disord 1999;10(Suppl 1):46-49.
  10. Boeve B. Corticobasal Degeneration. In: Adler C, Ahlskog J, eds. Parkinson's Disease and Movement Disorders: Diagnosis and Treatment Guidelines for the Practicing Physician. Totawa, NJ: Humana, 2000:253-261.
  11. Caselli R. Focal and asymmetric cortical degeneration syndromes. The Neurologist 1995;1:1-19.
  12. Riley D, Lang A, Lewis A, Resch L, Ashby P, Hornykiewicz O, et al. Cortical-basal ganglionic degeneration. Neurology 1990;40:1203-1212.
  13. Boeve B, Parisi J, Dickson D, Baker M, Hutton M, Wszolek Z, et al. Familial dementia/parkinsonism/motor neuron disease with corticobasal degeneration pathology but absence of a tau mutation. Neurobiol Aging 2002;23:S269.
  14. Bower J, Maraganore D, McDonnell S, Rocca W. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 1999;52:1214-1220.
  15. Rinne J, Lee M, Thompson P, Marsden C. Corticobasal degeneration: a clinical study of 36 cases. Brain 1994;117: 1183-1196.
  16. Wenning G, Litvan I, Jankovic J, Granata R, Mangone C, McKee A, et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry 1998;64:184-189.
  17. Litvan I, Goetz C, Lang A, eds. Corticobasal Degeneration and Related Disorders. Phildelphia: Lippincott, Williams & Wilkins, 2000.
  18. Leiguarda R, Lees A, Merello M, Starkstein S, Marsden C. The nature of apraxia in corticobasal degeneration. J Neurol Neurosurg Psychiatry 1994;57:455-459.
  19. Caselli R, Stelmach G, Caviness J, Timmann D, Royer T, Boeve B, et al. A kinematic study of progressive apraxia with and without dementia. Mov Disord 1999;14:276-287.
  20. Boeve BF, Maraganore DM, Parisi JE, Ivnik RJ, Westmoreland BF, Dickson DW, et al. Corticobasal degeneration and frontotemporal dementia presentations in a kindred with nonspecific histopathology. Dem Geriatr Cog Disord 2002;13(2):80-90.
  21. Ball J, Lantos P, Jackson M, Marsden C, Scadding J, Rossor M. Alien hand sign in association with Alzheimer's histopathology. J Neurol Neurosurg Psychiatry 1993;56:1020-1023.
  22. Doody R, Jankovic J. The alien hand and related signs. J Neurol Neurosurg Psychiatry 1992;55:806-810.
  23. Feinberg T, Schindler R, Flanagan N, Haber L. Two alien hand syndromes. Neurology 1992;42:19-24.
  24. Gasquoine P. Alien hand sign. J Clin Exp Neuropsychol 1993;15:653-667.
  25. Goldberg G, Bloom K. The alien hand sign: localization, lateralization and recovery. Am J Phys Med & Rehabil 1990;69:228-238.
  26. Thompson P, Day B, Rothwell J, Brown P, Britton T, Marsden C. The myoclonus in corticobasal degeneration: evidence for two forms of cortical reflex myoclonus. Brain 1994;117:1197-1207.
  27. Thompson PD, Shibasaki H. Myoclonus in corticobasal degeneration and other neurodegenerations. Adv Neurol 2000;82:69-81.
  28. Gottlieb D, Robb K, Day B. Mirror movements in the alien hand syndrome. Am J Phys Med Rehabil 1992;71:297-300.
  29. Kompoliti K, Goetz C, Boeve B, Maraganore D, Ahlskog J, Marsden C, et al. Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol 1998;55:957-961.
  30. Grimes DA, Lang AE, Bergeron CB. Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology 1999;53(9):1969-1974.
  31. Frattali C, Duffy J, Litvan I, Patsalides A, Grafman J. Yes/no reversals as neurobehavioral sequela: a disorder of language, praxis, or inhibitory control? Eur J Neurol 2003;10:103-106.
  32. Frattali CM, Grafman J, Patronas N, Makhlouf F, Litvan I. Language disturbances in corticobasal degeneration. Neurology. 2000;54(4):990-992.
  33. Lang A. Cortical basal ganglionic degeneration presenting with "progressive loss of speech output and orofacial dyspraxia." J Neurol Neurosurg Psychiatry 1992;55:1101.
  34. Litvan I, Cummings J, Mega M. Neuropsychiatric features of corticobasal degeneration. J Neurol Neurosurg Psychiat 1998;65:717-721.
  35. Cummings J, Litvan I. Neuropsychiatric aspects of corticobasal degeneration. In: Litvan I, Goetz C, Lang A, eds. Corticobasal Degeneration and Related Disorders. Philadelphia: Lippincott Williams & Wilkins, 2000, 147-152.
  36. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47(5):1113-1124.
  37. Geda Y, Boeve B, Parisi J, Dickson D, Maraganore D, Ahlskog J, et al. Neuropsychiatric features in 20 cases of pathologically-diagnosed corticobasal degeneration. Mov Disord 2000;15(Suppl 3):229.
  38. Maraganore D, Ahlskog J, Petersen R. Progressive asymmetric rigidity with apraxia: a distinct clinical entity [abstract]. Mov Disord 1992;7(Supp 1):80.
  39. Kumar R, Bergeron C, Pollanen M, Lang A. Cortical-basal ganglionic degeneration. In: Jankovic J, Tolosa E, eds. Parkinson's Disease and Movement Disorders, 3rd ed. Baltimore: Williams & Wilkins, 1998:297-316.
  40. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
  41. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology 1996;47:1-9.
  42. Movement Disorders Symposium on Cortical-Basal Ganglionic Degeneration and Other Asymmetric Cortical Degeneration Syndromes. Mov Disord 1996;11:346-357.
  43. Boeve BF, Maraganore DM, Parisi JE, Ahlskog JE, Graff-Radford N, Caselli RJ, et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999;53(4):795-800.
  44. Schneider J, Watts R, Gearing M, Brewer R, Mirra S. Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology 1997;48:959-969.
  45. Neary D, Snowden J, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
  46. Dickson D, Bergeron C, Chin S, Duyckaerts C, Horoupian D, Ikeda K, et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002;61:935-946.
  47. Houlden H, Baker M, Morris H, MacDonald N, Pickering-Brown S, Adamson J, et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 2001;56:1702-1706.
  48. Urakami K, Wada K, Arai H, Sasaki H, Kanai M, Shoji M, et al. Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsy. J Neurol Sci 2001;183:95-98.
  49. Pillon B, Blin J, Vidailhet M, Deweer B, Sirigu A, Dubois B, et al. The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology 1995;45:1477-1483.
  50. Massman P, Kreiter K, Jankovic J, Doody R. Neuropsychological functioning in cortical-basal ganglionic degeneration: differentiation from Alzheimer's disease. Neurology 1996;46:720-726.
  51. Westmoreland B, Boeve B, Maraganore D, Ahlskog J. The EEG in cortical-basal ganglionic degeneration. Mov Disord 1996;11:352.
  52. Westmoreland B, Boeve B, Parisi J, Dickson D, Maraganore D, Ahlskog J, et al. Electroencephalographic findings in clinically- and/or pathologically-diagnosed corticobasal degeneration. Mov Disord 2000;15(Suppl 3):229.
  53. Strafella A, Ashby P, Lang A. Reflex myoclonus in cortical-basal ganglionic degeneration involves a transcortical pathway. Mov Disord 1997;12:360-369.
  54. Hauser RA, Murtaugh FR, Akhter K, Gold M, Olanow CW. Magnetic resonance imaging of corticobasal degeneration. J Neuroimaging 1996;6(4):222-226.
  55. Ballan G, Tison F, Dousset V, Vidailhet M, Agid Y, Henry P. Study of cortical atrophy with magnetic resonance imaging in corticobasal degeneration. Rev Neurolog 1998;154(3):224-227.
  56. Frasson E, Moretto G, Beltramello A, Smania N, Pampanin M, Stegagno C, et al. Neuropsychological and neuroimaging correlates in corticobasal degeneration. Ital J Neurol Sci 1998;19(5):321-328.
  57. Soliveri P, Monza D, Paridi D, Radice D, Grisoli M, Testa D, et al. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology 1999;53(3):502-507.
  58. Schrag A, Good CD, Miszkiel K, Morris HR, Mathias CJ, Lees AJ, et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000;54(3):697-702.
  59. Savoiardo M, Grisoli M, Girotti F. Magnetic resonance imaging in CBD, related atypical parkinsonian disorders, and dementias. Adv Neurol 2000;82:197-208.
  60. Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Dong Y, Hayashi T, et al. Atrophy of the corpus callosum, cortical hypometabolism, and cognitive impairment in corticobasal degeneration. Arch Neurol 1998;55(5):609-614.
  61. Macia F, Yekhlef F, Ballan G, Delmer O, Tison F. T2-hyperintense lateral rim and hypointense putamen are typical but not exclusive of multiple system atrophy. Arch Neurol 2001;58:1024-1026.
  62. Winkelmann J, Auer DP, Lechner C, Elbel G, Trenkwalder C. Magnetic resonance imaging findings in corticobasal degeneration. Mov Disord 1999;14(4):669-673.
  63. Doi T, Iwasa K, Makifuchi T, Takamori M. White matter hyperintensities on MRI in a patient with corticobasal degeneration. Acta Neurol Scand 1999;99(3):199-201.
  64. Josephs K, Tang-Wai D, Boeve B, Knopman D, Dickson D, Parisi J, et al. Clinicopathologic and imaging correlates in corticobasal degeneration. Neurology 2002;58:A132.
  65. Sawle G, Brooks D, Marsden C, Frackowiak R. Corticobasal degeneration: a unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. Brain 1991; 114:541-556.
  66. Blin J, Vidailhet M-J, Pillon B, Dubois B, Feve J-R, Agid Y. Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET. Mov Disord 1992;4:348-354.
  67. Brooks DJ. Functional imaging studies in corticobasal degeneration. Adv Neurol 2000;82:209-215.
  68. Okuda B, Tachibana H, Kawabata K, Takeda M, Sugita M. Comparison of brain perfusion in corticobasal degeneration and Alzheimer's disease. Dem Geriatr Cog Disord 2001;12(3):226-231.
  69. Pirker W, Asenbaum S, Bencsits G, Prayer D, Gerschlager W, Deecke L, et al. beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. Mov Disord 2000;15(6):1158-1167.
  70. Okuda B, Tachibana H, Kawabata K, Takeda M, Sugita M. Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy. Alz Dis Assoc Disord 2000;14(1):46-52.
  71. Zhang L, Murata Y, Ishida R, Saitoh Y, Mizusawa H, Shibuya H. Differentiating between progressive supranuclear palsy and corticobasal degeneration by brain perfusion SPET. Nucl Med Commun 2001;22(7):767-772.
  72. Hauser M, Mullan B, Boeve B, Maraganore D, Ahlskog J, Parisi J, et al. SPECT findings in clinically- and/or pathologically-diagnosed corticobasal degeneration. Mov Disord 2000;15(Suppl 3):221.
  73. Lehman M, Duffy J, Boeve B, Parisi J, Dickson D, Maraganore D, et al. Speech and language disorders associated with corticobasal degeneration. J Med Speech Lang Dis 2003;11:131-146.
  74. Lerner A, Friedland R, Riley D, Whitehouse P, Lanska D, Vick N, et al. Dementia with pathological findings of cortical-basal ganglionic degeneration. Ann Neurol 1992;32:271.
  75. Lennox G, Jackson M, Lowe J. Corticobasal degeneration manifesting as a frontal lobe dementia. Ann Neurol 1994;36:273-274.
  76. Boeve B, Maraganore D, Parisi J, Ahlskog J, Graff-Radford N, Muenter M, et al. Clinical heterogeneity in patients with pathologically diagnosed cortical-basal ganglionic degeneration. Mov Disord 1996;11:351-352.
  77. Boeve B, Parisi J, Maraganore D, Ahlskog J, Caselli R, Graff-Radford N, et al. Clinicopathologic heterogeneity in clinically- and/or pathologically-diagnosed cortical-basal ganglionic degeneration. J Neurol Sci 1997;150:S109-S110.
  78. Lippa C, Cohen R, Smith T, Drachman D. Primary progressive aphasia with focal neuronal achromasia. Neurology 1991;41:882-886.
  79. Arima K, Uesugi H, Fujita I, Sakurai Y, Oyanagi S, Andoh S, et al. Corticonigral degeneration with neuronal achroma-sia presenting with primary progressive aphasia: ultrastructural and immunocytochemical studies. J Neurol Sci 1994;127:186-197.
  80. Ikeda K, Akiyama H, Iritani S, Kase K, Arai T, Niizato K, et al. Corticobasal degeneration with primary progressive aphasia and accentuated cortical lesion in superior temporal gyrus: case report and review. Acta Neuropathol 1996;92:534-539.
  81. Sakurai Y, Hashida H, Uesugi H, Arima K, Murayama S, Bando M, et al. A clinical profile of corticobasal degeneration presenting as primary progressive aphasia. European Neurology 1996;36(3):134-137.
  82. Tang-Wai D, Josephs K, Boeve B, Dickson D, Parisi J, Petersen R. Pathologically confirmed corticobasal degeneration presenting with visuospatial dysfunction. Neurology 2003;61:1134-1135.
  83. Boeve B, Maraganore D, Parisi J, Ahlskog J, Muenter M, Graff-Radford N, et al. Disorders mimicking the "classical" clinical syndrome of cortical-basal ganglionic degeneration: report of nine cases. Movement Disorders 1996;11:351.
  84. Davis P, Bergeron C, McLachlan D. Atypical presentation of progressive supranuclear palsy. Ann Neurol 1985; 17:337-343.
  85. Ford B, Fahn S. 60-year-old woman with parkinsonism and unilateral dystonia. Mov Disord 1996;11:355-356.
  86. Gearing M, Olson D, Watts R, Mirra S. Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. Neurology 1994;44:1015-1024.
  87. Saint-Hilaire M-H, Handler J, McKee A, Feldman R. Clinical overlap between corticobasal ganglionic degeneration and progressive supranuclear palsy. Mov Disord 1996;11:356.
  88. Scully R, Mark E, McNeely W, McNeely B. Case records of the Massachusetts General Hospital (Case 46-1993). N Engl J Med 1993;329:1560-1567.
  89. Rey GJ, Tomer R, Levin BE, Sanchez-Ramos J, Bowen B, Bruce JH. Psychiatric symptoms, atypical dementia, and left visual field inattention in corticobasal ganglionic degeneration. Mov Disord 1995;10(1):106-110.
  90. Boeve B, Parisi J, Dickson D, Maraganore D, Ahlskog J, Graff-Radford N, et al. Demographic and clinical findings in 20 cases of pathologically-diagnosed corticobasal degeneration. Mov Disord 2000;15(Suppl 3):228.
  91. Horoupian D, Wasserstein P. Alzheimer's disease pathology in motor cortex in dementia with Lewy bodies clinically mimicking corticobasal degeneration. Acta Neuropathol 1999;98:317-322.
  92. Grimes DA, Bergeron CB, Lang AE. Motor neuron disease-inclusion dementia presenting as cortical-basal ganglionic degeneration. Mov Disord 1999;14(4):674-680.
  93. Josephs K, Holton J, Rossor M, Braendgaard H, Ozawa T, Fox N, et al. Neurofilament inclusion body disease: a new proteinopathy? Brain 2003;126:2291-2303.
  94. Caselli RJ. Asymmetric cortical degeneration syndromes. Curr Opin Neurol 1996;9(4):276-280.
  95. Caselli R. Asymmetric cortical degeneration syndromes: clinicopathologic considerations. Mov Disord 1996;11:347-348.
  96. Litvan I, Agid Y, Goetz C, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathological study. Neurology 1997;48:119-125.
  97. Reed L, Wszolek Z, Hutton M. Phenotypic correlations in FTDP-17. Neurobiol Aging 2001;22:89-107.
  98. Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 2000;25(4):402-405.
  99. Boeve B. Diagnosis and management of the non-alzheimer dementias. In: Noseworthy JW, ed. Neurologic Therapeutics. London: Martin Dunitz, 2003:2826-2854.
  100. Boeve B, Silber M. Sleep disorders and dementia and related degenerative disorders. In: Carney PR, Berry RB, Geyer J, eds. Sleep Medicine. Philadelphia: Lippincott Williams & Wilkins, 2003, in press.
  101. Boeve B, Silber M, Ferman T, Lucas J, Parisi J. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 2001;16:622-630.
  102. Bugiani O, Murrell JR, Giaccone G, Hasegawa M, Ghigo G, Tabaton M, et al. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol 1999;58(6):667-677.

Was this article helpful?

0 0

Post a comment